Second, we evaluated the MDR2-KO mouse, which spontaneously exhibits primary sclerosing cholangitis (PSC), a chronic liver disease; with targeted disruption of the multi-drug resistance gene 2 (Abcb4). This evidence concerns the gene ABCB4 and pancreatic serous cystadenoma.